b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">29110042</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>02</Month>\n            <Day>07</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>02</Month>\n            <Day>15</Day>\n        </DateRevised>\n        <Article PubModel="Print">\n            <Journal>\n                <ISSN IssnType="Electronic">1432-1173</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>68</Volume>\n                    <Issue>12</Issue>\n                    <PubDate>\n                        <Year>2017</Year>\n                        <Month>Dec</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete</Title>\n                <ISOAbbreviation>Hautarzt</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>[Acne inversa/hidradenitis suppurativa: A\xc2\xa0challenge for the future].</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>994-998</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00105-017-4079-0</ELocationID>\n            <Abstract>\n                <AbstractText>Acne inversa (AI)/hidradenitis suppurativa is a chronic recurrent inflammatory dermatosis with signs of a systemic disease. AI is characterized by typical skin alterations in body areas bearing apocrine glands. The care of the AI patients in Germany is still inadequate. This situation might be significantly improved through the following efforts: (i) shortening of the time between the disease onset and the diagnosis/start of therapy; (ii) the in-depth investigation of AI pathogenesis with the aim of identifying innovative therapeutic targets and blood biomarkers; (iii) establishing a method for quantifying the severity of the disease, which takes into account both the clinical assessment and objective laboratory parameters and the self-assessment of the patient (e.g., Dermatology Life Quality Index [DLQI]); (iv) the elaboration of a clear algorithm for the interdisciplinary treatment of patients, which, in addition to the therapy of skin lesions, also includes lifestyle-modification measures and takes into consideration the systemic character of AI. This article describes the current problems of medical care for AI patients and outlines how we can achieve the predetermined goals.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Sabat</LastName>\n                    <ForeName>R</ForeName>\n                    <Initials>R</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Interdisziplin\xc3\xa4re Gruppe Molekulare Immunpathologie, Dermatologie/Med. Immunologie, Charit\xc3\xa9 - Universit\xc3\xa4tsmedizin Berlin, Charit\xc3\xa9platz\xc2\xa01, 10117, Berlin, Deutschland. robert.sabat@charite.de.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Psoriasis Forschungs- und BehandlungsCentrum, Klinik f\xc3\xbcr Dermatologie, Venerologie und Allergologie und Institut f\xc3\xbcr Medizinische Immunologie, Charit\xc3\xa9 - Universit\xc3\xa4tsmedizin Berlin, Charit\xc3\xa9platz\xc2\xa01, 10117, Berlin, Deutschland. robert.sabat@charite.de.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>ger</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D016454">Review</PublicationType>\n            </PublicationTypeList>\n            <VernacularTitle>Acne inversa/Hidradenitis suppurativa: Eine Herausforderung f\xc3\xbcr die Zukunft.</VernacularTitle>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Germany</Country>\n            <MedlineTA>Hautarzt</MedlineTA>\n            <NlmUniqueID>0372755</NlmUniqueID>\n            <ISSNLinking>0017-8470</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D007378">Interleukins</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C439524">TNF protein, human</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>XEO71E2E45</RegistryNumber>\n                <NameOfSubstance UI="C415368">interleukin-22</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>\n                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D017497" MajorTopicYN="N">Hidradenitis Suppurativa</DescriptorName>\n                <QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>\n                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>\n                <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>\n                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D033183" MajorTopicYN="N">Interdisciplinary Communication</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007378" MajorTopicYN="N">Interleukins</DescriptorName>\n                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000070516" MajorTopicYN="N">Intersectoral Collaboration</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D024821" MajorTopicYN="N">Metabolic Syndrome</DescriptorName>\n                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>\n                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D025242" MajorTopicYN="N">Spondylarthropathies</DescriptorName>\n                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>\n                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName>\n                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Biomarkers</Keyword>\n            <Keyword MajorTopicYN="N">IL-22</Keyword>\n            <Keyword MajorTopicYN="N">Metabolic syndrome</Keyword>\n            <Keyword MajorTopicYN="N">Spondyloarthritis</Keyword>\n            <Keyword MajorTopicYN="N">TNF-\xce\xb1</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2017</Year>\n                <Month>11</Month>\n                <Day>8</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>2</Month>\n                <Day>8</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2017</Year>\n                <Month>11</Month>\n                <Day>8</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29110042</ArticleId>\n            <ArticleId IdType="doi">10.1007/s00105-017-4079-0</ArticleId>\n            <ArticleId IdType="pii">10.1007/s00105-017-4079-0</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>J Immunol. 2011 Jan 15;186(2):1228-39</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21148041</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mediators Inflamm. 2016;2016:4097574</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27843200</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Dermatol. 2017 Nov;177(5):1385-1393</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28256718</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Dermatol. 2017 Nov;177(5):1401-1409</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28636793</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2016 Aug 4;375(5):422-34</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27518661</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Dermatol. 2011 Jun;164(6):1292-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21332464</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Dermatol. 2015 Dec;173(6):1546-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26198191</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Acta Derm Venereol. 2015 Jul;95(6):736-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25655759</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS One. 2012;7(2):e31810</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22359634</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biomarkers. 2009 Sep;14(6):432-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19627253</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Hautarzt. 2016 Jun;67(6):464-71</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27240668</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Invest Dermatol. 2017 Sep 20;:null</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28942360</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Dtsch Dermatol Ges. 2013 Aug;11(8):743-9, 743-50</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23565584</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Am Acad Dermatol. 2007 Apr;56(4):621-3</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17097366</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2012 Jan 12;366(2):158-64</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22236226</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Dermatol. 2017 Apr;176(4):993-1000</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27564400</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Dermatol. 2017 Jan;176(1):277-279</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27639175</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Am Acad Dermatol. 2012 Sep;67(3):422-8, 428.e1</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22182915</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Drug Discov. 2014 Jan;13(1):21-38</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24378801</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S4-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26470614</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Invest Dermatol. 2013 Mar;133(3):601-607</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23096707</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Am Acad Dermatol. 2017 Jan;76(1):49-53</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27793450</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>JAMA Dermatol. 2016 Apr;152(4):429-34</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26885728</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Biosci. 2015 Dec 15;5:68</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26674616</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Acta Derm Venereol. 2010 May;90(3):264-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20526543</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>JAMA Dermatol. 2017 Sep 1;153(9):897-905</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28538949</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Dermatology. 2016;232(5):606-612</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27649417</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'